Your browser doesn't support javascript.
loading
Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT.
Gilleece, Maria H; Shimoni, Avichai; Labopin, Myriam; Robinson, Stephen; Beelen, Dietrich; Socié, Gerard; Unal, Ali; Ganser, Arnold; Vitek, Antonin; Sengeloev, Henrik; Yakoub-Agha, Ibrahim; Tholouli, Eleni; Polge, Emmanuelle; Mohty, Mohamad; Nagler, Arnon.
Afiliação
  • Gilleece MH; Leeds Teaching Hospitals Trust, St James's University Hospital, Leeds, LS9 7TF, United Kingdom. mgilleece@nhs.net.
  • Shimoni A; Hematology and Bone Marrow Transplantation Division, Chaim Sheba Medical Center, Tel-Hashomer, Sackler School of Medicine, Tel-Aviv University, 6997801, Tel-Aviv, Israel.
  • Labopin M; EBMT Paris study office/CEREST-TC, Paris, France.
  • Robinson S; University Hospital Bristol NHS Foundation Trust, London, United Kingdom.
  • Beelen D; Department of Bone Marrow Transplantation, West German Cancer Center, University Hospital of Essen, Essen, Germany.
  • Socié G; Hematologie/Transplantation, Hôpital St Louis, Paris, CEDEX 10, France.
  • Unal A; Kapadokya BMT Center, Kayseri, Turkey.
  • Ganser A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Vitek A; Hematology Service, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Sengeloev H; Department of Haematology, Rigshospitalet, Copenhagen, Denmark.
  • Yakoub-Agha I; CHU de Lille, LIRIC, INSER U995, Université de Lille, Lille, France.
  • Tholouli E; Manchester Royal Infirmary, Manchester, United Kingdom.
  • Polge E; Acute Leukemia Working Party, European Society for Blood and Marrow Transplantation Paris Study Office/European Center for Biostatistical and Epidemiological Evaluation in Hematopoietic Cell Therapy (CEREST-TC), Paris, France.
  • Mohty M; Hôpital Saint Antoine, INSERM UMR 938, Paris, France; Université Pierre et Marie Curie, Paris, France.
  • Nagler A; Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Blood Cancer J ; 11(5): 88, 2021 05 12.
Article em En | MEDLINE | ID: mdl-33980810
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Neoplasia Residual / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Neoplasia Residual / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article